Skip to main content

Advertisement

Fig. 4 | Cancer Cell International

Fig. 4

From: miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway

Fig. 4

Suppression of KIF26B inhibits tumor formation ability of HCC cells in vivo. ad The in vivo effect of KIF26B was evaluated in xenograft mouse models bearing tumors originating from HCC-LM3 cells via tumor volume, photon flux and tumor weight; n = 6 per group. e, f Expression of KIF26B and Ki67 were detected between KIF26B shRNA and negative control groups in node mouse tumor tissues

Back to article page